logo

Aditya BSL Pharma & Hlthcare Reg IDCW-R

₹0

0.00(0%)
NAV as of . Log in to view Live prices

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Aditya BSL Pharma & Hlthcare Reg IDCW-R

as of 20 Oct 2026, 22:05 PM

Scheme Asset Size₹950.31 Cr
Expense Ratio1.94%
Cash Holding3.17267%
Fund TypeOpen-End
PlanDividend
BenchmarkBSE Healthcare TR INR
Launch Date2019-07-11
Exit LoadExit load of 1.00% for investments if redeemed within 30 Days

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months 6.70%
In the last 3 months 18.72%
In the last 6 months 12.46%
In the last 1 Years 13.96%
In the last 3 Years 0.82%
In the last 5 Years 0.83%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE12.42%
Apollo Hospitals Enterprise LtdHealthcareE7.31%
Torrent Pharmaceuticals LtdHealthcareE4.75%
J.B. Chemicals & Pharmaceuticals LtdHealthcareE4.73%
Aurobindo Pharma LtdHealthcareE4.37%
Ajanta Pharma LtdHealthcareE3.99%
Mankind Pharma LtdHealthcareE3.89%
Lupin LtdHealthcareE3.73%
Abbott India LtdHealthcareE3.65%
Fortis Healthcare LtdHealthcareE3.31%
Emcure Pharmaceuticals LtdHealthcareE3.17%
Cipla LtdHealthcareE2.98%
Shilpa Medicare LtdHealthcareE2.92%
Ipca Laboratories LtdHealthcareE2.43%
Sai Life Sciences LtdHealthcareE2.26%
Procter & Gamble Health LtdHealthcareE2.24%
Corona Remedies LtdHealthcareE2.06%
Alkem Laboratories LtdHealthcareE2.03%
Thyrocare Technologies LtdHealthcareE1.89%
Jupiter Life Line Hospitals LtdHealthcareE1.84%
Divi's Laboratories LtdHealthcareE1.82%
Metropolis Healthcare LtdHealthcareE1.57%
Sanofi Consumer Healthcare India LtdHealthcareE1.52%
Dr. Lal PathLabs LtdHealthcareE1.38%
Pfizer LtdHealthcareE1.36%
Dr Reddy's Laboratories LtdHealthcareE1.36%
Alembic Pharmaceuticals LtdHealthcareE1.25%
Biocon LtdHealthcareE1.23%
Gland Pharma LtdHealthcareE1.20%
Piramal Pharma LtdHealthcareE1.16%
Anthem Biosciences LtdHealthcareE1.13%
Vijaya Diagnostic Centre LtdHealthcareE1.08%
Medi Assist Healthcare Services LtdHealthcareE1.01%
Suraksha Diagnostic LtdHealthcareE1.01%
GlaxoSmithKline Pharmaceuticals LtdHealthcareE0.75%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE0.71%
Jubilant Pharmova LtdHealthcareE0.66%
Vinati Organics LtdBasic MaterialsE0.65%
Clearing Corporation Of India Limited-CR3.23%
Net Receivables / (Payables)-C0.05%

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

96.83%

Cash

3.17%

Equity sector allocation

Loading chart…

Basic Materials

0.65%

Healthcare

96.18%

Others

3.17%

Fund House Contact Details

Websitehttps://mutualfund.adityabirlacapital.com/
Phone+91 22 4356 8008/ 8000
Aditya Birla Sun Life AMC Ltd

Asset Management Company

About Aditya BSL Pharma & Hlthcare Reg IDCW-R

Investment Objective of the Scheme

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Key Features of The Fund

5-year return

+12.80%

Fund Manager

Dhaval Shah

Risk Profile

Very High Risk

Expense Ratio

1.94%

Fund Size

₹950.31 Cr

Aditya BSL Pharma & Hlthcare Reg IDCW-R Summary

Aditya BSL Pharma & Hlthcare Reg IDCW-R NAV, Returns, Performance & Details

Aditya BSL Pharma & Hlthcare Reg IDCW-R is currently priced at ₹23.4, as of 20 Oct 2026, 22:05 PM. The fund has recorded a change of ₹0.05 (0.21%), indicating its recent movement in the market.

Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Fund Details and Key Information

Aditya BSL Pharma & Hlthcare Reg IDCW-R is an open-ended mutual fund that invests based on its stated objective and benchmark.

Key details:

  • Asset Size: ₹950.31 Cr

  • Expense Ratio: 1.94%

  • Cash Holding: 3.17%

  • Plan Type: Dividend

  • Benchmark: BSE Healthcare TR INR

  • Launch Date: 2019-07-11

  • Exit Load: 1.00

These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Returns and Performance

Aditya BSL Pharma & Hlthcare Reg IDCW-R has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.

Returns:

  • 1 Month: 6.70%

  • 3 Months: 18.72%

  • 6 Months: 12.46%

  • 1 Year: 13.96%

  • 3 Years: 0.82%

  • 5 Years: 0.83%

Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Risk Level and Volatility

Understanding risk is important before investing. Aditya BSL Pharma & Hlthcare Reg IDCW-R falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.

Risk Level: Very High Risk

The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Portfolio Allocation

The asset allocation of Aditya BSL Pharma & Hlthcare Reg IDCW-R shows how investments are distributed across asset classes.

  • Equity Allocation: 96.83%

  • Cash Allocation: 3.17%

This allocation plays a key role in determining the fund’s risk and return profile.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Sector Allocation

Aditya BSL Pharma & Hlthcare Reg IDCW-R diversifies its investments across sectors to reduce risk.

Sector Holding Detail

  • Basic Materials: 0.65%

  • Healthcare: 96.18%

Sector allocation data helps investors understand which industries the fund is focusing on.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Fund House

Aditya BSL Pharma & Hlthcare Reg IDCW-R is managed by:

AMC Name: Aditya Birla Sun Life AMC Ltd

A strong fund house with a proven track record can improve investor confidence.

Aditya BSL Pharma & Hlthcare Reg IDCW-R Minimum Investment

Investors can start investing in Aditya BSL Pharma & Hlthcare Reg IDCW-R with:

Minimum Investment: ₹1,000

This makes the fund accessible for both beginners and experienced investors.

Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy